Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development / Steven J. Potts, David A. Eberhard, Keith A. Wharton Jr.
Publication year: 2015
: 978-1-4939-2681-7
Gathers diverse histopathology in drug development settings ranging from discovery research to human clinical trials. While many current applications of quantitative histology and molecular pathology in the biopharmaceutical industry are focused on oncology.
: Histology, Biochemical markers, Biomarkers, Drug Discovery, Medical Pharmacology, Medicine, Biopharma, Companion diagnostics, Flagship Biosciences, In situ hybridization, Initial New Drug, Application (IND), Pathology, Pharmaceutical research, Tissue analysis, Tissue biopsy
